ATProto Browser

ATProto Browser

Experimental browser for the Atmosphere

Post

Precision medicine for #AMR is making real progress. BiomX's BX211 phage therapy for diabetic foot osteomyelitis (S. aureus) just hit a major milestone in Phase II. Significant ulcer reduction over 91 days. #PhageTherapy #Biotech #InfectiousDisease www.insideprecisionmedicine.com/topics/preci...

Mar 31, 2025, 6:46 PM

Record data

{
  "uri": "at://did:plc:iwvzssh3agid2v4ytqrl67xa/app.bsky.feed.post/3llozfdplos24",
  "cid": "bafyreiccs7pfvutzdyzdjywsgxpdoilmi5bxjo3dk4audlmatfjrtpuq4m",
  "value": {
    "text": "Precision medicine for #AMR  is making real progress.\n\nBiomX's BX211 phage therapy for diabetic foot osteomyelitis (S. aureus) just hit a major milestone in Phase II.\n\nSignificant ulcer reduction over 91 days. #PhageTherapy #Biotech\n#InfectiousDisease\n\nwww.insideprecisionmedicine.com/topics/preci...",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://www.insideprecisionmedicine.com/topics/precision-medicine/91-days-later-biomxs-phage-fights-off-diabetic-bone-infection-in-phase-ii/",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreido4hq4bnjpwbfpuh7jp5gogiuqndycqfjwyv46wk3rsrfbkdiniy"
          },
          "mimeType": "image/jpeg",
          "size": 218564
        },
        "title": "91 Days Later: BiomX’s Phage Fights Off Diabetic Bone Infection in Phase II",
        "description": "CEO Jonathan Solomon explains the significance of BX211—a phage therapy for diabetic foot osteomyelitis—in developing a new precision medicine modality."
      }
    },
    "langs": [
      "en"
    ],
    "facets": [
      {
        "index": {
          "byteEnd": 27,
          "byteStart": 23
        },
        "features": [
          {
            "tag": "AMR",
            "$type": "app.bsky.richtext.facet#tag"
          }
        ]
      },
      {
        "index": {
          "byteEnd": 223,
          "byteStart": 210
        },
        "features": [
          {
            "tag": "PhageTherapy",
            "$type": "app.bsky.richtext.facet#tag"
          }
        ]
      },
      {
        "index": {
          "byteEnd": 232,
          "byteStart": 224
        },
        "features": [
          {
            "tag": "Biotech",
            "$type": "app.bsky.richtext.facet#tag"
          }
        ]
      },
      {
        "index": {
          "byteEnd": 251,
          "byteStart": 233
        },
        "features": [
          {
            "tag": "InfectiousDisease",
            "$type": "app.bsky.richtext.facet#tag"
          }
        ]
      },
      {
        "index": {
          "byteEnd": 300,
          "byteStart": 253
        },
        "features": [
          {
            "uri": "https://www.insideprecisionmedicine.com/topics/precision-medicine/91-days-later-biomxs-phage-fights-off-diabetic-bone-infection-in-phase-ii/",
            "$type": "app.bsky.richtext.facet#link"
          }
        ]
      }
    ],
    "createdAt": "2025-03-31T18:46:30.031Z"
  }
}